Log in

NASDAQ:DARE - Dare Bioscience Stock Price, Forecast & News

$1.66
+0.04 (+2.47 %)
(As of 01/19/2020 05:28 AM ET)
Today's Range
$1.62
Now: $1.66
$1.68
50-Day Range
$0.80
MA: $0.90
$1.66
52-Week Range
$0.69
Now: $1.66
$3.25
Volume2.18 million shs
Average Volume3.77 million shs
Market Capitalization$27.69 million
P/E RatioN/A
Dividend YieldN/A
Beta1.86
Daré Bioscience, Inc, a clinical-stage biopharmaceutical company, focuses on developing and marketing women's reproductive health products in the United States. The company intends to develop therapies in the areas of contraception, vaginal health, sexual health, and fertility. Its product candidates include Ovaprene, a non-hormonal monthly contraceptive; and SST-6007, a topical sildenafil cream for female sexual arousal disorder. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DARE
CUSIPN/A
Phone858-926-7655

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.59 per share

Profitability

Net Income$-16,740,000.00

Miscellaneous

Employees5
Market Cap$27.69 million
Next Earnings Date4/6/2020 (Estimated)
OptionableNot Optionable

Receive DARE News and Ratings via Email

Sign-up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


I call it my "Dividend Map", and I'll show you exactly where to find the safest companies that pay the highest yields. (HINT: Texas has 6 of these companies sending huge payouts that average 77%!). I'm willing to send you my Map... but only if you

Dare Bioscience (NASDAQ:DARE) Frequently Asked Questions

What is Dare Bioscience's stock symbol?

Dare Bioscience trades on the NASDAQ under the ticker symbol "DARE."

How were Dare Bioscience's earnings last quarter?

Dare Bioscience Inc (NASDAQ:DARE) announced its quarterly earnings results on Thursday, November, 14th. The biotechnology company reported ($0.20) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.21) by $0.01. View Dare Bioscience's Earnings History.

When is Dare Bioscience's next earnings date?

Dare Bioscience is scheduled to release their next quarterly earnings announcement on Monday, April 6th 2020. View Earnings Estimates for Dare Bioscience.

What price target have analysts set for DARE?

2 equities research analysts have issued twelve-month price objectives for Dare Bioscience's shares. Their forecasts range from $3.00 to $3.00. On average, they expect Dare Bioscience's share price to reach $3.00 in the next year. This suggests a possible upside of 80.7% from the stock's current price. View Analyst Price Targets for Dare Bioscience.

What is the consensus analysts' recommendation for Dare Bioscience?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dare Bioscience in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dare Bioscience.

Has Dare Bioscience been receiving favorable news coverage?

Press coverage about DARE stock has been trending very negative on Sunday, according to InfoTrie Sentiment. The research group identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Dare Bioscience earned a news sentiment score of -3.0 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View News Stories for Dare Bioscience.

Are investors shorting Dare Bioscience?

Dare Bioscience saw a increase in short interest in December. As of December 31st, there was short interest totalling 649,000 shares, an increase of 5.8% from the December 15th total of 613,500 shares. Based on an average daily volume of 252,000 shares, the short-interest ratio is currently 2.6 days. Currently, 3.9% of the company's stock are short sold. View Dare Bioscience's Current Options Chain.

Who are some of Dare Bioscience's key competitors?

What other stocks do shareholders of Dare Bioscience own?

Who are Dare Bioscience's key executives?

Dare Bioscience's management team includes the folowing people:
  • Ms. Sabrina Martucci Johnson, Pres, CEO, Sec. & Director (Age 52)
  • Ms. Lisa Walters-Hoffert, Chief Financial Officer (Age 60)
  • Mr. Mark Walters, VP of Operations (Age 64)
  • Ms. MarDee J. Haring-Layton, VP of Accounting & Fin. (Age 43)
  • Dr. David Friend, Chief Scientific Officer

How do I buy shares of Dare Bioscience?

Shares of DARE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Dare Bioscience's stock price today?

One share of DARE stock can currently be purchased for approximately $1.66.

How big of a company is Dare Bioscience?

Dare Bioscience has a market capitalization of $27.69 million. The biotechnology company earns $-16,740,000.00 in net income (profit) each year or ($1.09) on an earnings per share basis. Dare Bioscience employs 5 workers across the globe.View Additional Information About Dare Bioscience.

What is Dare Bioscience's official website?

The official website for Dare Bioscience is http://www.darebioscience.com/.

How can I contact Dare Bioscience?

Dare Bioscience's mailing address is 3655 NOBEL DRIVE SUITE 260, SAN DIEGO CA, 92122. The biotechnology company can be reached via phone at 858-926-7655 or via email at [email protected]


MarketBeat Community Rating for Dare Bioscience (NASDAQ DARE)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  294 (Vote Outperform)
Underperform Votes:  217 (Vote Underperform)
Total Votes:  511
MarketBeat's community ratings are surveys of what our community members think about Dare Bioscience and other stocks. Vote "Outperform" if you believe DARE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DARE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel